Diana Peiteado

1.6k total citations
60 papers, 685 citations indexed

About

Diana Peiteado is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Diana Peiteado has authored 60 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Rheumatology, 21 papers in Immunology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Diana Peiteado's work include Rheumatoid Arthritis Research and Therapies (28 papers), Spondyloarthritis Studies and Treatments (17 papers) and Monoclonal and Polyclonal Antibodies Research (12 papers). Diana Peiteado is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (28 papers), Spondyloarthritis Studies and Treatments (17 papers) and Monoclonal and Polyclonal Antibodies Research (12 papers). Diana Peiteado collaborates with scholars based in Spain, United States and Netherlands. Diana Peiteado's co-authors include Alejandro Villalba, E. Martín‐Mola, Eugenio de Miguel, Alejandro Balsa, Laura Nuño, I. Monjo, Dora Pascual‐Salcedo, Concepción Castillo Castillo, Chamaida Plasencia and María‐Eugenia Miranda‐Carús and has published in prestigious journals such as PLoS ONE, Scientific Reports and Annals of the Rheumatic Diseases.

In The Last Decade

Diana Peiteado

53 papers receiving 670 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diana Peiteado Spain 15 473 281 130 100 96 60 685
Natalia Soria Spain 5 474 1.0× 255 0.9× 96 0.7× 74 0.7× 33 0.3× 6 753
Alejandro Villalba Spain 15 387 0.8× 325 1.2× 50 0.4× 65 0.7× 39 0.4× 27 635
Jean-Charles Piette France 12 470 1.0× 207 0.7× 71 0.5× 85 0.8× 101 1.1× 15 861
Lale Öçal Türkiye 16 456 1.0× 266 0.9× 74 0.6× 97 1.0× 67 0.7× 39 754
Jose Gabriel Erdozain Spain 8 546 1.2× 186 0.7× 65 0.5× 135 1.4× 84 0.9× 12 611
Joan Plaza Spain 8 398 0.8× 118 0.4× 97 0.7× 162 1.6× 89 0.9× 8 588
Antonia Calligaro Italy 16 494 1.0× 222 0.8× 100 0.8× 223 2.2× 78 0.8× 37 681
Aliki Iniotaki Greece 8 293 0.6× 282 1.0× 164 1.3× 41 0.4× 98 1.0× 21 641
Valentina Leone United Kingdom 11 249 0.5× 189 0.7× 67 0.5× 205 2.0× 61 0.6× 20 561
Anne Bruns Germany 13 525 1.1× 553 2.0× 106 0.8× 55 0.6× 32 0.3× 18 903

Countries citing papers authored by Diana Peiteado

Since Specialization
Citations

This map shows the geographic impact of Diana Peiteado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Peiteado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Peiteado more than expected).

Fields of papers citing papers by Diana Peiteado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diana Peiteado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Peiteado. The network helps show where Diana Peiteado may publish in the future.

Co-authorship network of co-authors of Diana Peiteado

This figure shows the co-authorship network connecting the top 25 collaborators of Diana Peiteado. A scholar is included among the top collaborators of Diana Peiteado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diana Peiteado. Diana Peiteado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Novella-Navarro, Marta, Virginia Ruíz-Esquide, I. Monjo, et al.. (2024). Subsequent biologic and targeted synthetic disease modifying anti rheumatic drugs after fulfilling difficult-to-treat rheumatoid arthritis criteria: a survival analysis. Clinical Rheumatology. 43(9). 2817–2823. 1 indexed citations
2.
Benavent, Diego, Judith Marín‐Corral, Victoria Navarro‐Compán, et al.. (2024). Natural language processing to identify and characterize spondyloarthritis in clinical practice. RMD Open. 10(2). e004302–e004302. 3 indexed citations
3.
Novella-Navarro, Marta, Alejandro Villalba, Elisa Fernández-Fernández, et al.. (2023). Patient and physician assessment in difficult-to-treat rheumatoid arthritis: patterns of subjective perception at early stages of b/tsDMARD treatment. RMD Open. 9(3). e003382–e003382. 7 indexed citations
4.
Juárez, Maria, Diego Benavent, Victoria Navarro‐Compán, et al.. (2023). POS0676 THE CHALLENGE OF IDENTIFYING DIFFICULT-TO-TREAT AXIAL SPONDYLOARTHRITIS IN CLINICAL PRACTICE: RESULTS FROM LA PAZ-SPA COHORT. Annals of the Rheumatic Diseases. 82. 619–620. 1 indexed citations
5.
Benavent, Diego, Chamaida Plasencia‐Rodríguez, Marta Novella-Navarro, et al.. (2022). Achievement rate and predictive factors of the recommended therapeutical target in patients with axial spondyloarthritis who remain on biological therapy: a prospective cohort study in Spain. BMJ Open. 12(4). e057850–e057850. 10 indexed citations
6.
Cordero, Oscar J., Irene Viéitez, Laura Nuño, et al.. (2022). Study of Plasma Anti-CD26 Autoantibody Levels in a Cohort of Treatment-Naïve Early Arthritis Patients. Archivum Immunologiae et Therapiae Experimentalis. 70(1). 12–12. 1 indexed citations
7.
Monjo, I., Elisa Fernández-Fernández, Diana Peiteado, Alejandro Balsa, & Eugenio de Miguel. (2022). Diagnostic validity of ultrasound including extra-cranial arteries in giant cell arteritis. Clinical Rheumatology. 42(4). 1163–1169. 11 indexed citations
8.
Bang, Holger, Laura Nuño, Diana Peiteado, et al.. (2020). Improved classification of rheumatoid arthritis with a score including anti-acetylated ornithine antibodies. Scientific Reports. 10(1). 19263–19263. 10 indexed citations
9.
Monjo, I., Elisa Fernández-Fernández, Diana Peiteado, Alejandro Balsa, & Eugenio de Miguel. (2020). OP0180 DIAGNOSTIC VALIDITY OF ULTRASOUND INCLUDING EXTRA-CRANIAL ARTERIES IN GIANT CELL ARTERITIS. Annals of the Rheumatic Diseases. 79. 112–112. 2 indexed citations
10.
Ortiz, Ana M., Laura Nuño, Diana Peiteado, et al.. (2019). THU0096 PERSISTENT HIGH DISEASE ACTIVITY IN THE ANTI-CARBAMYLATED PROTEIN ANTIBODY POSITIVE EARLY ARTHRITIS PATIENTS INDEPENDENTLY OF TREATMENT. Annals of the Rheumatic Diseases. 78. 319–319. 1 indexed citations
11.
Nuño, Laura, Alejandro Villalba, Diana Peiteado, et al.. (2019). Two populations of circulating PD-1hiCD4 T cells with distinct B cell helping capacity are elevated in early rheumatoid arthritis. Lara D. Veeken. 58(9). 1662–1673. 65 indexed citations
12.
Hernández‐Breijo, Borja, Victoria Navarro‐Compán, Ana Martínez‐Feito, et al.. (2018). FRI0186 Concomitant csdmards influence clinical response to tnf inhibitors only in overweight patients with axial spondyloarthritis. Annals of the Rheumatic Diseases. 77. 634–634. 1 indexed citations
13.
Monjo, I., et al.. (2018). THU0447 No advantage of methotrexate in the treatment of giant cell arteritis. Annals of the Rheumatic Diseases. 77. 435–436. 1 indexed citations
14.
Benito, Marta, Diana Peiteado, Alejandro Balsa, et al.. (2017). FRI0062 Synovial fluid treg cells secrete il-17 and at the same time are potent suppressors of tresp cell proliferation, tnf alpha and ifn gamma production. Annals of the Rheumatic Diseases. 76. 501–502.
15.
Jurado‐Guerrero, Teresa, Chamaida Plasencia‐Rodríguez, Ana Martínez‐Feito, et al.. (2017). Predictive Value of Serum Infliximab Levels at Induction Phase in Rheumatoid Arthritis Patients. The Open Rheumatology Journal. 11(1). 75–87. 13 indexed citations
16.
Nuño, Laura, Ana M. Ortiz, Diana Peiteado, et al.. (2017). Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients. Scientific Reports. 7(1). 12023–12023. 18 indexed citations
17.
Plasencia, Chamaida, E. Kneepkens, Gertjan Wolbink, et al.. (2015). Comparing Tapering Strategy to Standard Dosing Regimen of Tumor Necrosis Factor Inhibitors in Patients with Spondyloarthritis in Low Disease Activity. The Journal of Rheumatology. 42(9). 1638–1646. 29 indexed citations
18.
Miguel, Eugenio de, et al.. (2013). Achilles enthesis ultrasound: the importance of the bursa in spondyloarthritis.. PubMed. 31(3). 422–7. 14 indexed citations
19.
Pascual‐Salcedo, Dora, Sara García, G. Bonilla, et al.. (2013). THU0219 The Infliximab Dose Increase is Not Correlated with Clinical Improvement in RA Patients. Annals of the Rheumatic Diseases. 72. A238–A238. 1 indexed citations
20.
Plasencia, Chamaida, Dora Pascual‐Salcedo, Laura Nuño, et al.. (2012). Influence of immunogenicity on the efficacy of longterm treatment of spondyloarthritis with infliximab. Annals of the Rheumatic Diseases. 71(12). 1955–1960. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026